Kristoffer Watten Brudvik
- MD, PhD
Publications 2021
Genomic and prognostic heterogeneity among RAS/BRAF(V600E)/TP53 co-mutated resectable colorectal liver metastases
Mol. Oncol., 15 (4), 830-845
DOI 10.1002/1878-0261.12885
Survival Outcomes After Portal Vein Embolization and Liver Resection Compared With Liver Transplant for Patients With Extensive Colorectal Cancer Liver Metastases
JAMA Surg., 156 (6), 550-557
DOI 10.1001/jamasurg.2021.0267
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
Genome Med., 13 (1), 143
DOI 10.1186/s13073-021-00956-1
Publications 2020
High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases
Clin. Colorectal Canc., 19 (1), E26-E47
DOI 10.1016/j.clcc.2019.09.003
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity
Clin. Cancer Res., 26 (15), 4107-4119
DOI 10.1158/1078-0432.CCR-19-3637
Preoperative detection of colorectal liver metastases: DWI alone or combined with MDCT is no substitute for Gd-EOB-DTPA-enhanced MRI
Acta Radiol., 61 (3), 0284185119864000-311
DOI 10.1177/0284185119864000
Publications 2019
RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases
Ann. Surg., 269 (1), 120-126
DOI 10.1097/SLA.0000000000002319
Limitations of molecular biomarkers in patients with resectable colorectal liver metastases
Chin. Clin. Oncol., 8 (5), 48
DOI 10.21037/cco.2019.08.02
Survey of the attitudes of hepatopancreatobiliary surgeons in northern Europe to resection of choledochal cysts in asymptomatic Western adults
BJS Open, 3 (6), 785-792
DOI 10.1002/bjs5.50208
Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases
EJSO, 45 (12), 2340-2346
DOI 10.1016/j.ejso.2019.07.017
Contemporary practice and short-term outcomes after liver resections in a complete national cohort
Langenbecks Arch. Surg., 404 (1), 11-19
DOI 10.1007/s00423-018-1737-3
Treatment Options for Metastatic Gastrointestinal Stromal Tumors to the Liver: A Review
Semin. Liver Dis., 39 (3), 395-401
DOI 10.1055/s-0039-1685517
Characterization of early recurrences following liver resection by ALPPS and two stage hepatectomy in patients with colorectal liver-metastases and small future liver remnants; a translational substudy of the LIGRO-RCT
HPB, 21 (8), 1017-1023
DOI 10.1016/j.hpb.2018.12.003
Publications 2018
Unplanned readmission and outpatient examination 90-days after acute appendectomy in adults
Am. J. Surg., 216 (2), 217-221
DOI 10.1016/j.amjsurg.2017.07.020
Survival after resection of colorectal liver metastases in octogenarians and sexagenarians compared to their respective age-matched national population
Hepatobil. Surg. Nutr., 7 (4), 234-241
DOI 10.21037/hbsn.2017.09.03
Association between the lymph node ratio and hepatic tumor burden: importance for resectable colorectal liver metastases?
Hepatobil. Surg. Nutr., 7 (3), 206-208
DOI 10.21037/hbsn.2018.03.02
Risk for hemorrhage after pancreatoduodenectomy with venous resection
Langenbecks Arch. Surg., 403 (8), 949-957
DOI 10.1007/s00423-018-1721-y
Publications 2017
SURGERY KRAS mutations and hepatic recurrence after treatment of colorectal liver metastases
Nat. Rev. Gastroenterol. Hepatol., 14 (11), 638-639
DOI 10.1038/nrgastro.2017.129
Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making
EJSO, 43 (5), 875-883
DOI 10.1016/j.ejso.2017.02.014
Follow-up After Surgery for Pancreatic Ductal Adenocarcinoma Steps Toward an International Consensus
Pancreas, 46 (1), E2-E3
DOI 10.1097/MPA.0000000000000689
Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival
Colorectal Dis., 19 (8), 731-738
DOI 10.1111/codi.13622
Aspirin, Colorectal Cancer, and Cause of Death: A Complex Landscape Reply
J. Clin. Oncol., 35 (5), 569-+
DOI 10.1200/JCO.2016.70.8263
Factors associated with hernia recurrence after laparoscopic total extraperitoneal repair for inguinal hernia: a 2-year prospective cohort study
Hernia, 21 (5), 729-735
DOI 10.1007/s10029-017-1634-7
Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases
Ann. Surg. Oncol., 24 (8), 2113-2121
DOI 10.1245/s10434-017-5818-2
Publications 2016
Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study
J. Clin. Oncol., 34 (21), 2501-+
DOI 10.1200/JCO.2015.65.3519
Validation of Clinical Risk Scores for Laparoscopic Liver Resections of Colorectal Liver Metastases: A 10-Year Observed Follow-Up Study
J. Surg. Oncol., 114 (6), 757-763
DOI 10.1002/jso.24391
Re "Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections"
HPB, 18 (6), 557
DOI 10.1016/j.hpb.2016.02.008
Is Extended Lymphadenectomy Needed for Elderly Patients With Gastric Adenocarcinoma?
Ann. Surg. Oncol., 23 (8), 2391-2397
DOI 10.1245/s10434-016-5260-x
Publications 2015
Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases
Ann. Surg. Oncol., 22 (12), 4029-4037
DOI 10.1245/s10434-015-4482-7
Circulating Tumor Cells in Patients With Colorectal Liver Metastasis Predict Impaired Survival
Ann. Surg., 261 (1), 164-171
DOI 10.1097/SLA.0000000000000580
Publications 2012
Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer
Cancer Immunol. Immunother., 61 (7), 1045-1053
DOI 10.1007/s00262-011-1174-4
Modulation of T cell immune functions by the prostaglandin E2-cAMP pathway in chronic inflammatory states
Br. J. Pharmacol., 166 (2), 411-419
DOI 10.1111/j.1476-5381.2011.01800.x
Kinetics and Activation Requirements of Contact-Dependent Immune Suppression by Human Regulatory T Cells
J. Immunol., 188 (11), 5459-5466
DOI 10.4049/jimmunol.1101367
Publications 2011
Protein kinase A antagonist inhibits beta-catenin nuclear translocation, c-Myc and COX-2 expression and tumor promotion in Apc(Min/+) mice
Mol. Cancer, 10, 149
DOI 10.1186/1476-4598-10-149